-+ 0.00%
-+ 0.00%
-+ 0.00%

MaxCyte FY2026 Revenue expected to be more than $34.500M vs $32.211M Est

Benzinga·11/10/2026 13:33:41
Listen to the news
MaxCyte (NASDAQ:MXCT) FY2026 Revenue expected to be more than $34.500M vs $32.211M Est